These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1018 related articles for article (PubMed ID: 15161039)

  • 1. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line.
    Ferreira MJ; Gyémánt N; Madureira AM; Tanaka M; Koós K; Didziapetris R; Molnár J
    Anticancer Res; 2005; 25(6B):4173-8. PubMed ID: 16309213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids.
    Molnár J; Gyémánt N; Mucsi I; Molnár A; Szabó M; Körtvélyesi T; Varga A; Molnár P; Tóth G
    In Vivo; 2004; 18(2):237-44. PubMed ID: 15113052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells.
    Gyémánt N; Tanaka M; Antus S; Hohmann J; Csuka O; Mándoky L; Molnár J
    In Vivo; 2005; 19(2):367-74. PubMed ID: 15796199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells.
    Lee G; Piquette-Miller M
    Can J Physiol Pharmacol; 2001 Oct; 79(10):876-84. PubMed ID: 11697747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells.
    Madureira AM; Spengler G; Molnár A; Varga A; Molnár J; Abreu PM; Ferreira MJ
    Anticancer Res; 2004; 24(2B):859-64. PubMed ID: 15161038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
    Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
    Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis and necrosis by resistance modifiers benzazoles and benzoxazines on tumour cell line mouse lymphoma L5718 Mdr+cells.
    Varga A; Aki-Sener E; Yalcin I; Temiz-Arpaci O; Tekiner-Gulbas B; Cherepnev G; Molnar J
    In Vivo; 2005; 19(6):1087-91. PubMed ID: 16277027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
    Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL
    Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones.
    Ferreira MJ; Gyémánt N; Madureira AM; Molnár J
    Anticancer Res; 2005; 25(5):3259-62. PubMed ID: 16101136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y; Qian F; Wei D; Liu J
    J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance reversal by 3-formylchromones in human colon cancer and human mdr1 gene-transfected mouse lymphoma cells.
    Baráth Z; Radics R; Spengler G; Ocsovszki I; Kawase M; Motohashi N; Shirataki Y; Shah A; Molnár J
    In Vivo; 2006; 20(5):645-9. PubMed ID: 17091772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.
    Gyémánt N; Tanaka M; Molnár P; Deli J; Mándoky L; Molnár J
    Anticancer Res; 2006; 26(1A):367-74. PubMed ID: 16475720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists.
    Fu J; Chen Z; Cen J; Ruan C
    Chin Med J (Engl); 2000 Mar; 113(3):228-31. PubMed ID: 11775252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDR-reversal activity of chalcones.
    Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
    In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
    Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
    Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.